Tuesday, December 06, 2022
Outlook.com
Outlook India
Outlook Business
+

Health Tech

The Mumbai-based start-up earlier raised Rs 48.75 crore from three investors including OrbiMed, 3one4 Capital and Vertex Ventures

He will oversee all aspects of the clinical technology company's business in Europe and APAC and manage its Indian operations

The genomics biotech start-up raised around $15.5 to $20 million in the funding round at a valuation of $150 million